PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28292264-8	2017	Crizotinib and AZD4547 exerted marked antitumor effects exclusively in PDX models with cMet (G30,G31) and FGFR2(G03) amplification.	Crizotinib	0-10	fibroblast growth factor receptor 2	Homo sapiens	106-111	
28292264-9	2017	Interestingly, synergistic antitumor activity was observed in G03 (FGFR2-amplifed and cMet non-amplified but IHC [2+]) with simultaneous treatment with Crizotinib and ADZ4547 at day 30 post-treatment.	Crizotinib	152-162	fibroblast growth factor receptor 2	Homo sapiens	67-72